Understanding Your BBS9 Diagnosis
At a Glance
BBS9-related Bardet-Biedl syndrome is an inherited condition caused by pathogenic or likely pathogenic variants in the BBS9 gene, which affects cell cilia. Symptoms vary widely, so lifelong checks of vision, kidney health, growth, and development help guide individualized care.
Receiving a diagnosis of Bardet-Biedl Syndrome (BBS) can feel like finally finding a name for a long and confusing journey, but it also brings a new wave of questions and concerns. It is common to feel overwhelmed or even guilty, but it is important to know that you did nothing to cause this condition [1]. BBS is a genetic condition inherited in an autosomal recessive pattern, meaning the genetic changes were passed down naturally and were not caused by anything you did [2].
What is Bardet-Biedl Syndrome?
BBS is a rare, multisystem condition, meaning it can affect several different parts of the body at the same time [2]. It belongs to a group of disorders called ciliopathies. In these conditions, the tiny, hair-like structures on the surface of cells (called cilia) do not work correctly [3]. Because cilia are found in almost every part of the body—from the eyes to the kidneys—their malfunction can lead to the wide variety of symptoms seen in BBS.
This specific type is called BBS9. This means the genetic change is located on the BBS9 gene (also known as the PTHB1 gene) [4]. While all types of BBS share common features, the BBS9 gene provides instructions for a core part of the “BBSome,” a group of proteins that helps move vital materials within the cell’s cilia [5]. It is important to note that simply finding a “Variant of Uncertain Significance” (VUS) on a genetic test is not enough to confirm BBS9; the variants must be classified as pathogenic or likely pathogenic by a specialist.
Why Diagnosis Often Takes Time
If it felt like a long road to get here, you are not alone. Many families do not receive a formal diagnosis until around age 9 [6]. There are several reasons why this delay is common:
- Symptoms appear at different ages: Some signs, like having an extra finger or toe (polydactyly), are present at birth [7]. Others, like vision changes or rapid weight gain, may not become obvious until early childhood [8].
- Symptoms are gradual: Vision loss often begins as “night blindness,” which can be hard for a young child to describe or for a parent to notice [9].
- Specialists see pieces, not the whole: A person might see a kidney specialist for one issue and an eye doctor for another, without the two pieces being linked together until later [6].
Primary Features of BBS9
While everyone with BBS9 is unique, research has identified several “major” features that frequently appear together [3].
| Feature | What It Means |
|---|---|
| Retinal Dystrophy | A progressive breakdown of the light-sensing cells in the back of the eye, often starting with difficulty seeing in the dark [10]. |
| Obesity/Weight Gain | Rapid weight gain and an intense, constant hunger called hyperphagia often begin in early childhood [7]. |
| Polydactyly | Being born with extra fingers or toes, which is often the very first sign of BBS [3]. |
| Renal Abnormalities | Structural or functional issues with the kidneys, which can range from mild to more serious [11]. |
| Learning Differences | Some individuals may experience delays in reaching milestones or have specific learning needs [4]. |
Understanding the Uncertainty
One of the hardest parts of a BBS9 diagnosis is that the genetic test cannot perfectly predict how the condition will affect you or your child over time [10].
Research shows significant “variability,” meaning one person with BBS9 may have very different symptoms than another person with the same genetic change [4]. Group-level studies suggest that variants in “core” genes like BBS9 may be more likely to have kidney involvement compared to some other types, but this is a trend, not a guarantee for any individual [5][8]. Some may have severe symptoms across many systems, while others might mainly experience vision issues with very few other signs [10].
Moving Forward with Your Care Team
Because BBS9 affects many systems, care will likely be followed by a team of specialists rather than just one doctor. Current international guidelines emphasize the importance of lifelong monitoring to manage symptoms as they appear [12]. This usually involves regular check-ups for vision, kidney function, and growth [12].
Participating in registries, such as the Clinical Registry Investigating Bardet-Biedl Syndrome (CRIBBS), can help researchers learn more about BBS9 and may connect your family with future clinical trials specifically designed for this condition [NCT02329210]. Your focus now will be on building a care team that understands the full picture of your health and supports your unique needs.
Common questions in this guide
What is BBS9-related Bardet-Biedl syndrome?
Can a variant of uncertain significance confirm a BBS9 diagnosis?
What symptoms and features are associated with BBS9?
Why can it take years to diagnose Bardet-Biedl syndrome?
What monitoring is usually important after a BBS9 diagnosis?
Will everyone with BBS9 have the same symptoms?
Did something I did cause BBS9-related Bardet-Biedl syndrome?
Get notified when new evidence is published on BBS9-related ciliopathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (12)
- 1
[The Bardet-Biedl Syndrome - Diagnosis and Follow-up].
Rohrschneider K, Bolz HJ
Klinische Monatsblatter fur Augenheilkunde 2020; (237(3)):239-247 doi:10.1055/a-1118-3748.
PMID: 32182628 - 2
Collaborative effort: managing Bardet-Biedl syndrome in pediatric patients. Case series and a literature review.
Nowak-Ciołek M, Ciołek M, Tomaszewska A, et al.
Frontiers in endocrinology 2024; (15()):1424819 doi:10.3389/fendo.2024.1424819.
PMID: 39092285 - 3
Streamlining Diagnosis of Bardet-Biedl Syndrome: New Diagnostic Algorithm With Updated Criteria.
Pomeroy JJ, Richards J, Sweeney BR, et al.
American journal of medical genetics. Part A 2026; (200(10)):2181-2198 doi:10.1002/ajmg.a.70199.
PMID: 42175648 - 4
Novel homozygous protein-truncating mutation of BBS9 identified in a Chinese consanguineous family with Bardet-Biedl syndrome.
Tang HY, Xie F, Dai RC, Shi XL
Molecular genetics & genomic medicine 2021; (9(8)):e1731 doi:10.1002/mgg3.1731.
PMID: 34212515 - 5
Meta-analysis of genotype-phenotype associations in Bardet-Biedl syndrome uncovers differences among causative genes.
Niederlova V, Modrak M, Tsyklauri O, et al.
Human mutation 2019; (40(11)):2068-2087 doi:10.1002/humu.23862.
PMID: 31283077 - 6
Genetic characterization of Italian patients with Bardet-Biedl syndrome and correlation to ocular, renal and audio-vestibular phenotype: identification of eleven novel pathogenic sequence variants.
Esposito G, Testa F, Zacchia M, et al.
BMC medical genetics 2017; (18(1)):10 doi:10.1186/s12881-017-0372-0.
PMID: 28143435 - 7
Bardet-Biedl syndrome: Weight patterns and genetics in a rare obesity syndrome.
Pomeroy J, Krentz AD, Richardson JG, et al.
Pediatric obesity 2021; (16(2)):e12703 doi:10.1111/ijpo.12703.
PMID: 32700463 - 8
Molecular and phenotypic characteristics of Bardet-Biedl syndrome in Chinese patients.
Gao S, Zhang Q, Ding Y, et al.
Orphanet journal of rare diseases 2024; (19(1)):149 doi:10.1186/s13023-024-03150-9.
PMID: 38584252 - 9
Homozygosity mapping identified a novel protein truncating mutation (p.Ser100Leufs*24) of the BBS9 gene in a consanguineous Pakistani family with Bardet Biedl syndrome.
Khan MA, Mohan S, Zubair M, Windpassinger C
BMC medical genetics 2016; (17()):10 doi:10.1186/s12881-016-0271-9.
PMID: 26846096 - 10
Autosomal Recessive Rod-Cone Dystrophy with Mild Extra-Ocular Manifestations Due to a Splice-Affecting Variant in BBS9.
Deitch I, Itskov S, Panneman D, et al.
Current issues in molecular biology 2024; (46(3)):2566-2575 doi:10.3390/cimb46030163.
PMID: 38534779 - 11
Risk Factors for Severe Renal Disease in Bardet-Biedl Syndrome.
Forsythe E, Sparks K, Best S, et al.
Journal of the American Society of Nephrology : JASN 2017; (28(3)):963-970 doi:10.1681/ASN.2015091029.
PMID: 27659767 - 12
Bardet-Biedl syndrome improved diagnosis criteria and management: Inter European Reference Networks consensus statement and recommendations.
Dollfus H, Lilien MR, Maffei P, et al.
European journal of human genetics : EJHG 2024; (32(11)):1347-1360 doi:10.1038/s41431-024-01634-7.
PMID: 39085583
This page explains BBS9-related Bardet-Biedl syndrome for informational purposes and does not replace medical advice. A genetics specialist and your care team can interpret your test results and recommend monitoring for your situation.